Financial & Tax Architects’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-12,940
Closed -$625K – 114
2025
Q2
$625K Buy
12,940
+390
+3% +$19.9K 0.15% 74
2025
Q1
$696K Buy
12,550
+726
+6% +$39.3K 0.17% 75
2024
Q4
$570K Buy
11,824
+1,525
+15% +$77.5K 0.15% 79
2024
Q3
$594K Buy
10,299
+584
+6% +$31.5K 0.15% 71
2024
Q2
$471K Buy
9,715
+2,445
+34% +$118K 0.13% 76
2024
Q1
$353K Buy
7,270
+1,903
+35% +$92.9K 0.1% 78
2023
Q4
$267K Sell
5,367
-186
-3% -$9.1K 0.08% 82
2023
Q3
$298K Sell
5,553
-69
-1% -$3.68K 0.09% 68
2023
Q2
$303K Sell
5,622
-704
-11% -$37.9K 0.09% 69
2023
Q1
$344K Sell
6,326
-18
-0.3% -$876 0.11% 62
2022
Q4
$311K Buy
+6,344
New +$278K 0.11% 67
2022
Q3
– Sell
-6,621
Closed -$331K – 78
2022
Q2
$331K Sell
6,621
-821
-11% -$43.6K 0.13% 65
2022
Q1
$382K Sell
7,442
-103
-1% -$5.32K 0.14% 70
2021
Q4
$378K Sell
7,545
-60
-0.8% -$2.97K 0.15% 82
2021
Q3
$367K Buy
7,605
+35
+0.5% +$1.78K 0.17% 84
2021
Q2
$399K Sell
7,570
-152
-2% -$7.93K 0.2% 80
2021
Q1
$382K Buy
+7,722
New +$371K 0.21% 79

Other funds holding SNY

Financial & Tax Architects's SNY Position: Q3 2025 in Review

Financial & Tax Architects sold out of Sanofi (SNY) in Q3 2025, closing a stake of 12,940 shares — an estimated $625K sold.

Financial & Tax Architects first reported a position in SNY in Q1 2021 and held it in 17 quarters. The position peaked at $696K in Q1 2025. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Financial & Tax Architects reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Financial & Tax Architects sold 12,940 Sanofi shares in Q3 2025, an estimated $625K.
  • Financial & Tax Architects first reported a position in Sanofi in Q1 2021 and held it in 17 quarters.
  • Financial & Tax Architects's Sanofi position peaked at $696K in Q1 2025.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Financial & Tax Architects's 13F filing for Q3 2025, filed 5 Nov 2025.